Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice.
about
Differential gene expression patterns in cyclooxygenase-1 and cyclooxygenase-2 deficient mouse brainCannabinoid activation of PPAR alpha; a novel neuroprotective mechanismSystematic Review of Pharmacological Properties of the Oligodendrocyte LineageNon-steroidal anti-inflammatory drugs and cognitive function: are prostaglandins at the heart of cognitive impairment in dementia and delirium?Rational modulation of the innate immune system for neuroprotection in ischemic strokeImmune mechanisms in cerebral ischemic toleranceCyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) studyParecoxib is neuroprotective in spontaneously hypertensive rats after transient middle cerebral artery occlusion: a divided treatment response?Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microgliaCyclooxygenase- and cytochrome P450-derived eicosanoids in strokeIKK mediates ischemia-induced neuronal deathActivation of 5-lipoxygenase after oxygen-glucose deprivation is partly mediated via NMDA receptor in rat cortical neuronsDifferential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice.Inhibition of cyclooxygenase-2 by NS398 attenuates noise-induced hearing loss in mice.Cytosolic phospholipase A2 alpha inhibition prevents neuronal NMDA receptor-stimulated arachidonic acid mobilization and prostaglandin production but not subsequent cell death.Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse modelsAntioxidant CR-6 protects against reperfusion injury after a transient episode of focal brain ischemia in rats.Melatonin reduces infarction volume in a photothrombotic stroke model in the wild-type but not cyclooxygenase-1-gene knockout mice.Effects of Cyclooxygenase Inhibitors on Apoptotic Neuroretinal Cells.Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotectionNeuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor.Microsomal prostaglandin E synthase-1 and cyclooxygenase-2 are both required for ischaemic excitotoxicityNeuronal and nonneuronal COX-2 expression confers neurotoxic and neuroprotective phenotypes in response to excitotoxin challengeCyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic deathCyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity.Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets.Neuronal overexpression of cyclooxygenase-2 does not alter the neuroinflammatory response during brain innate immune activation.Interaction of PGHS-2 and glutamatergic mechanisms controlling the ovine fetal hypothalamus-pituitary-adrenal axisPurinergic signaling induces cyclooxygenase-1-dependent prostanoid synthesis in microglia: roles in the outcome of excitotoxic brain injury.Cytosolic phospholipase A2 alpha amplifies early cyclooxygenase-2 expression, oxidative stress and MAP kinase phosphorylation after cerebral ischemia in mice.Microsomal prostaglandin E synthase-1 contributes to ischaemic excitotoxicity through prostaglandin E2 EP3 receptors.Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2.Mechanisms contributing to cerebral infarct size after stroke: gender, reperfusion, T lymphocytes, and Nox2-derived superoxideMolecular and behavioral aspects of the actions of alcohol on the adult and developing brain.Induction of COX-2 enzyme and down-regulation of COX-1 expression by lipopolysaccharide (LPS) control prostaglandin E2 production in astrocytesStroke genomics: approaches to identify, validate, and understand ischemic stroke gene expression.Neuroprotective effects of andrographolide in a rat model of permanent cerebral ischaemia.Distinct cAMP signaling pathways differentially regulate alpha2C-adrenoceptor expression: role in serum induction in human arteriolar smooth muscle cells.NR2B-NMDA receptor mediated modulation of the tyrosine phosphatase STEP regulates glutamate induced neuronal cell deathTemporal changes of cytochrome P450 (Cyp) and eicosanoid-related gene expression in the rat brain after traumatic brain injury.
P2860
Q21184137-8EAAA24C-9C49-452C-9172-C6799AC322F4Q24681426-D19380DD-D76B-4B06-AB65-033886772637Q26768210-50B105CC-42AC-4715-832E-3B3966CD98D8Q26822022-359893F8-EDEC-4AC5-A0E6-17880BE332C1Q26851831-E6022E46-9F32-4706-9F0D-97A748868386Q27022067-31BB85FF-1DC9-4D5B-A701-161D82D2137DQ28210322-FC21EF30-8C77-46AD-9E42-8624BEA7D5BDQ28211961-32B8A090-FFEF-4ED0-AEEB-20C3CFEFA5DEQ28222555-E31BAE1F-D398-4954-8966-50C72EEFE336Q28271874-A714EBCE-1F76-4A64-973E-167525868972Q28281709-043539CF-BDDD-4216-A17A-5309490D537EQ28566836-392B3249-0122-40C5-9BCE-1A04DAB9F9CAQ30276622-0A549DEE-67DD-408B-94F7-ABFC3230B82EQ30388736-A48D993C-7759-463F-9568-95E54456E549Q30484548-9A8E1FEB-C472-4BCA-8660-59A6052A7B25Q30499792-4ECE4822-E398-443F-80E8-BB96A8FB8289Q30881194-ACF05011-8906-4F91-A225-61492E1A0BF1Q33252360-B1946AC3-64C2-43EA-9BCB-757B82A69869Q33443011-28FD44B4-470D-4F4E-83CB-5525D3842491Q33651797-9C9C0504-CD76-4DD9-8D4E-1650BC4D4D0BQ33719741-9E6ED180-8DA0-4D97-90AF-D80B57547D8BQ33730643-4382B51A-A0CC-4903-B957-98F49BB652DEQ33859381-8215959A-5D25-4C27-A41D-CFDA2286E7D8Q33863351-DEAD74CE-A539-481C-91A0-61EAE778F967Q33896920-B930227E-2515-45CD-AE06-E5996645784AQ33925611-3EF07732-4E42-45E1-914A-CD0B94029DA4Q33936122-D0F55592-2363-4DFA-A79E-E060A5CA093CQ33994979-9AD1E1D4-4A38-4FC7-A570-CEE02BECEFF9Q34055792-F10BA12A-5AC5-4525-835E-E2C261CC16F5Q34071481-A01BB3ED-04A2-4078-8FFB-26B036B5B4E2Q34112849-D6E29794-6BA6-44A0-A30C-DF6706B47DC2Q34155940-6ADACEA2-A7D4-48CD-9E49-2459F8EA3EC6Q34171222-3660816C-4690-475D-BA68-01775C881CCDQ34191211-C0A4104A-7D9B-4726-8FD8-E1F218674C56Q34244599-62F8CCE6-6E48-48F2-9DFC-7678F16A01A6Q34298120-BACC806C-25F5-4812-A769-A47657F7525AQ34342302-FA440A35-56EE-4991-8604-A35170D62F5CQ34345511-76D41A34-827D-462F-93B8-C9D5907D0A00Q34559448-6A7F22A1-531B-46FD-95D9-AF5712A51EE6Q34705038-BB8A5D92-5064-4D5D-ABC6-6657FB69476F
P2860
Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Reduced susceptibility to isch ...... clooxygenase-2-deficient mice.
@ast
Reduced susceptibility to isch ...... clooxygenase-2-deficient mice.
@en
Reduced susceptibility to isch ...... clooxygenase-2-deficient mice.
@nl
type
label
Reduced susceptibility to isch ...... clooxygenase-2-deficient mice.
@ast
Reduced susceptibility to isch ...... clooxygenase-2-deficient mice.
@en
Reduced susceptibility to isch ...... clooxygenase-2-deficient mice.
@nl
prefLabel
Reduced susceptibility to isch ...... clooxygenase-2-deficient mice.
@ast
Reduced susceptibility to isch ...... clooxygenase-2-deficient mice.
@en
Reduced susceptibility to isch ...... clooxygenase-2-deficient mice.
@nl
P2093
P2860
P356
P1476
Reduced susceptibility to isch ...... yclooxygenase-2-deficient mice
@en
P2093
M Nagayama
P2860
P304
P356
10.1073/PNAS.98.3.1294
P407
P577
2001-01-01T00:00:00Z